Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2022
Basis of Presentation and Summary of Significant Accounting Policies (Tables) LineItems  
Schedule of reconciliation of the components of cash and restricted cash
    March 31,  
(in thousands)   2022
(unaudited)		     2021
(unaudited)		  
Cash   $ 36,652     $ 19,052  
Restricted cash     125       75  
Restricted cash – noncurrent     207       210  
Total cash and restricted cash presented in the condensed consolidated statements of cash flows   $ 36,984     $ 19,337  

 
Schedule of liability deferred revenue
(in thousands)    Three
Months Ended
March 31,
2022
(unaudited)		     Year
Ended
December 31,
2021
(unaudited)  		  
Balance, beginning of period   $ 6,238     $ 5,439  
Deferral of revenue     6,008       22,964  
Recognition of unearned revenue     (6,985 )     (22,165 )
Balance, end of period   $ 5,261     $ 6,238  

 
Schedule of diluted weighted-average shares of common stock outstanding
   

March 31,
2022

(unaudited)

    

March 31,
2021

(unaudited)

  
Common stock warrants     2,753,408       3,333,791  
Stock options     8,094,544       6,553,893  
      10,847,952       9,887,684